Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pangenomic Health Inc C.NARA

Pangenomic Health Inc. is a precision health company. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform for consumers (Mindleap) and a clinical decision support... see more

Recent & Breaking News (CSE:NARA)

PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements

Canada NewsWire 7 days ago

PanGenomic Health Announces Completion of Consolidation

Canada NewsWire March 21, 2024

CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)

Newsfile March 19, 2024

PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE

Canada NewsWire March 18, 2024

PanGenomic Health Announces Withdrawal from AQSE

Canada NewsWire February 20, 2024

PanGenomic Health Announces Changes to Board of Directors

Canada NewsWire February 16, 2024

PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility

Canada NewsWire January 9, 2024

PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry

Canada NewsWire December 6, 2023

How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way

Newsfile November 22, 2023

PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests

Canada NewsWire November 17, 2023

PanGenomic Health Intends to Close Shares for Debt Settlement

Canada NewsWire November 1, 2023

PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023

Canada NewsWire August 30, 2023

PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement

Canada NewsWire August 9, 2023

PanGenomic Health Announces Director Resignations

Canada NewsWire July 13, 2023

PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments

Canada NewsWire July 6, 2023

PanGenomic Health Provides Update for NARA Product and Conversational AI

Canada NewsWire June 6, 2023

PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform

Canada NewsWire May 30, 2023

PanGenomic Health Announces Financial Results for the 2022 Fiscal Year

Canada NewsWire May 2, 2023

PanGenomic Health Announces AGM Results

Canada NewsWire May 2, 2023

PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants

Canada NewsWire April 21, 2023